BeiGene, Ltd.
ONC
$224.15
$4.201.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -409.75M | -662.17M | -857.27M | -506.81M | -767.54M |
| Total Depreciation and Amortization | 175.52M | 168.00M | 84.90M | 90.79M | 88.53M |
| Total Amortization of Deferred Charges | 4.77M | 4.78M | 3.79M | 4.45M | 4.11M |
| Total Other Non-Cash Items | 513.65M | 498.26M | 483.52M | 37.44M | 24.39M |
| Change in Net Operating Assets | -85.25M | -162.59M | -375.96M | -307.47M | -229.39M |
| Cash from Operations | 198.93M | -153.72M | -661.02M | -681.60M | -879.90M |
| Capital Expenditure | -405.80M | -505.97M | -543.34M | -570.37M | -581.89M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -67.03M | -54.75M | -108.21M | -10.00M | 180.36M |
| Cash from Investing | -472.83M | -560.72M | -651.55M | -580.37M | -401.54M |
| Total Debt Issued | 871.44M | 942.52M | 894.36M | 839.88M | 835.11M |
| Total Debt Repaid | -966.93M | -793.38M | -389.25M | -1.04B | -883.17M |
| Issuance of Common Stock | 233.06M | 184.50M | 181.79M | 151.79M | 149.81M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -14.49M | -14.49M | -14.49M | -15.55M | -15.55M |
| Other Financing Activities | -135.98M | -135.98M | -139.83M | -108.76M | -111.76M |
| Cash from Financing | 4.32M | 200.39M | 551.47M | 453.75M | 596.81M |
| Foreign Exchange rate Adjustments | -26.39M | -52.31M | -16.59M | 14.70M | -41.58M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -295.97M | -566.36M | -777.70M | -793.52M | -726.21M |